HealthTech

Asia is seeing a wave of digital health announcements, from AI diagnostics to telehealth platforms. Yet the pace of actual deployment remains uneven. Amit Yadav looks at the infrastructure and market signals that can help investors, healthcare operators, and policymakers distinguish experimentation from adoption at scale.

Japan Investment Corporation (JIC) will invest JPY2 billion ($12.7 million) in Red No. 1 Healthcare Investment Limited Partnership, which focuses on biotech, medical devices, and healthcare services startups.

Malaysia's Qmed Asia and United States chipmaker Intel will cooperate to develop a unified patient monitoring platform for hospitals, combining Intel's Patient Monitoring Hub Reference Implementation with Qmed Asia's healthcare software to consolidate fragmented bedside data into a centralized Smart Ward dashboard.

Connected hardware helped establish the foundation for digital elder care. The next phase will depend on AI-native devices that can understand context, respond conversationally, and support older adults and caregivers in real time.

Ant Group has completed a strategic investment in Boohee Health, becoming its largest external shareholder with a stake of over 28 percent, as the two companies deepen cooperation in weight management and AI-driven health services.

Asia Pacific's share of global medtech demand is expected to reach $132 billion by 2030, growing at 6.9 percent annually and faster than the global market, according to a new report by Bain & Company.

Biobot Surgical, a Singapore-based medical technology company developing robotic-assisted systems for prostate cancer diagnosis and treatment, has secured S$20 million ($15.4 million) in its latest financing round led by ClavystBio in partnership with ZIG Ventures.

Vinmec Healthcare System, under Vietnam's conglomerate Vingroup, has launched a nationwide network of High-Tech Robotic Surgery Centers, establishing Vietnam's first multi-connected robotic surgery ecosystem that links multiple robotic technologies across its hospital network.

The United States-based healthcare firm GRAIL has closed an equity financing deal in which Samsung affiliates, including Samsung C&T Corporation, invested $110 million through the purchase of GRAIL common stock at $70.05 per share.

Ovum, an Australian women's health company founded by Ariella Heffernan-Marks, has raised $4 million in seed funding to address the gender health gap, tripling its valuation just one year after securing $1.7 million in a pre-seed round.